home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  September 20, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 563 active entries

PX'Therapeutics SAS

7 Parvis Louis Néel - MINATEC BHT 52A
38040 Grenoble cedex 9
France

Phone: +33 (0)438 023 650
Fax: +33 (0)476 961 038

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

 
Located in Grenoble (France), PX’Therapeutics provides integrated biologics development and manufacturing contract services. Organized around technology platforms, PX’Therapeutics offers custom programs which may include, depending on clients' needs:
- murine antibody generation and development of chimeric, humanized and fully human mAbs
- mg to 100 g scale protein and mAb production
- expression systems: bacteria, insect cells, yeasts, mammalian cells
- R&D grade or GMP grade cell line development (CHO-PX or other cells)
- Process development
- small-mid scale GMP manufacturing
- regulatory expertise

PX’Therapeutics has been extensively involved in the discovery, development and manufacturing of drug targets, vaccines, cell-based products, therapeutic proteins and monoclonal antibodies with over 800 projects performed over the past 13 years through 200 customers (North America, Europe, Asia).


Selected Categories:
Product Company   Service Company
Contract
- Research
- Services

Last update of this entry: November 05, 2013

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.